Library.

“Collagen supplements in the United States are largely unregulated by the Food and Drug Administration due to the Dietary Supplement Health and Education Act of 1994.”

The claim is substantially accurate. DSHEA (1994) does exempt collagen supplements from FDA premarket approval and shifts the burden of proving unsafety to the FDA, which multiple peer-reviewed and medical sources confirm. However, "largely unregulated" overstates the situation: the FDA retains meaningful post-market authority including cGMP manufacturing standards, labeling enforcement, adulteration removal powers, and premarket safety review for new dietary ingredients. A more precise framing would be "largely exempt from premarket approval requirements" rather than "largely unregulated."

“The scientific evidence supporting the benefits of collagen supplements for non-cosmetic body systems, such as bones, joints, and digestion, is weaker or less established than the evidence for cosmetic benefits.”

This claim oversimplifies a complex evidence landscape. While digestive benefits of collagen supplements do rest on thin, mixed evidence, joint and osteoarthritis outcomes are supported by multiple reviews and meta-analyses — making them comparably or even better established than cosmetic claims. Critically, recent high-quality analyses show that positive cosmetic results are largely driven by industry-funded, lower-quality studies, with independently funded trials finding no significant skin benefits. Grouping all non-cosmetic domains as uniformly "weaker" misrepresents the actual state of the science.